AUA 2017 Prostate Cancer - Results from #49

Viewing 50-69 of 132 articles

AUA 2017: Statin Use, Serum Lipid Levels and Prostate Inflammation; Results from the Reduce Study

AUA 2017: Fasting Blood Glucose and Prostate Cancer Risk in the Finnish Randomized Study of Screening for Prostate Cancer

AUA 2017: The Effect of Prostate Cancer Treatment on Patient Reported Urinary and Sexual Function Varies by Disease Severity: 3-year Results From the Ceasar Study

AUA 2017: Best of Randomized Trials

AUA 2017: RP vs XRT—What About Propensity Weighted Studies?

AUA 2017: Best of Tertiary Care Center and Collaborative Research

AUA 2017: Introduction to comparative outcomes research

AUA 2017: Panel Discussion: 'The Uber Prostatectomist: Why Did You Do That and What Can You Prove?'

AUA 2017: Building an active surveillance program for community practice

AUA 2017: Active Surveillance and Dietary/Supplement Strategies

AUA 2017: Newly Diagnosed Prostate Cancer: Optimal Utilization of Tissue Biomarkers and Imaging

AUA 2017: Who to biopsy and repeat biopsy – MRI, biomarkers, and cost-effective questions

AUA 2017: Robot-assisted Salvage Node Dissection for Oligometastatic Nodal Disease Detected by 68 Gallium-PSMA PET/CT: A Multicenter Retrospective Series

AUA 2017: Multiparametric MRI – When, Who, and How to Interpret?

AUA 2017: Big Data in Prostate Cancer: Translating Big Data in Prostate Cancer to the Clinic

AUA 2017: Big Data in Prostate Cancer: DNA Repair Pathways in Metastatic Therapy Resistant Prostate Cancer

AUA 2017: Combination or Sequential Therapy for Castration-Resistant Prostate Cancer

AUA 2017: Postoperative Radiation Therapy for High-Risk/Locally Advanced Prostate Cancer

AUA 2017: The ProtecT Trial

AUA 2017: How I Screen - Panel

1
2
3
4
5
6
7